Mode
Text Size
Log in / Sign up
N/A N=30 Treatment

Management of Traumatic Bone Defects in Tibial Plateau Fractures With Antibiotic-Impregnated Biodegradable Calcium Sulfate Beads: A Prospective Clinical Trial

Tibial Fractures · Intra-Articular Fractures · Fracture Fixation, Internal

Enrolled (actual)
30
Serious AEs
3.3%
Results posted
Sep 2023
Primary outcome: Primary: Resorption of Study Device — 4 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Calcium Sulfate + Antibiotics + Internal Fixation (Device)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Ross Leighton
Primary completion
Apr 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Resorption of Study Device
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Pain Subscale
75.38
SECONDARY
Range of Motion
126.51
SECONDARY
Subsidence of Joint Surface
4
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Pain Subscale
75.38
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Pain Subscale
75.38
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Pain Subscale
75.38
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Pain Subscale
75.38
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Symptoms Subscale
70.69
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Symptoms Subscale
70.69
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Symptoms Subscale
70.69
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Symptoms Subscale
70.69
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Symptoms Subscale
70.69
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Activities of Daily Living Subscale
81.68
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Activities of Daily Living Subscale
81.68
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Activities of Daily Living Subscale
81.68
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Activities of Daily Living Subscale
81.68
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Activities of Daily Living Subscale
81.68
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Sports/Recreation Subscale
53.5
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Sports/Recreation Subscale
53.5
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Sports/Recreation Subscale
53.5
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Sports/Recreation Subscale
53.5
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Sports/Recreation Subscale
53.5
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Quality of Life Subscale
58.98
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Quality of Life Subscale
58.98
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Quality of Life Subscale
58.98
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Quality of Life Subscale
58.98
SECONDARY
Knee Injury Osteoarthritis Outcome Score - Quality of Life Subscale
58.98
SECONDARY
Range of Motion
126.51
SECONDARY
Range of Motion
126.51
SECONDARY
Range of Motion
126.51
SECONDARY
Resorption of Study Device
SECONDARY
Resorption of Study Device
SECONDARY
Resorption of Study Device

Summary

This is a prospective clinical trial of tibial plateau fractures treated with internal fixation and a calcium sulfate graft which can be mixed with antibiotics and molded into various bead sizes for implantation into bone defects. The graft material chosen for this study is STIMULAN Rapid Cure (Biocomposites, UK), which is approved for use as a bone void filler and may be mixed with a variety of antibiotics. The combination of STIMULAN + antibiotic in bead form is the "study device". Our primary study aim is to look at resorption and remodeling of the study device into bone. Another important aim of the study is to look at subsidence, or collapse, of the joint surface.

Eligibility Criteria

Inclusion Criteria

  • Adult (skeletally mature) men or women;
  • Acute, closed, tibial plateau fractures, Schatzker grade 1 through 5;
  • Internal fixation and use of study device per protocol;
  • Fracture repair within 30 days of injury;
  • Signed informed consent to participate in study.

Exclusion Criteria

  • Uncontrolled diabetes;
  • Severe degenerative or metabolic bone disease;
  • Malignancy;
  • Severe vascular or neurologic disease;
  • Alcoholism;
  • Substance abuse;
  • Use of systemic steroids;
  • Immunosuppressive therapy;
  • Hypercalcaemia;
  • Renal-compromised patients;
  • Osteomyelitis or chronic infection in the study limb;
  • Women who are pregnant or breast-feeding.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02456194). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search